Patent · US Active

Marker sequences for diagnosing and stratifying SLE patients

US11860162B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

Oncimmune Germany GmbH · DE

Inventors

Angelika Lüking · Bochum, DE
Peter Schulz-Knappe · Hemmingen, DE
Carmen THEEK · Herdecke, DE
Petra BUDDE · Dortmund, DE
Anna TELAAR · Dortmund, DE

Key dates

Filing date	Jul 6, 2020
Grant date	Jan 2, 2024
Priority date	—
Expiry date	Aug 5, 2041

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to methods for identifying markers for systemic lupus erythematosus (SLE) and to the markers identified with the aid of this method, which can differentiate between SLE and other autoimmune diseases on the one hand and between different SLE subgroups on the other hand. The invention also relates to panels, diagnostic devices and test kits which comprise these markers, and to the use and application thereof, for example for the diagnosis, prognosis and therapy control in SLE. The invention also relates to methods for screening and validating active substances for application in SLE subgroups.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.